Pharis Mohideen
CIK 1760395 · Chief Medical Officer · last filed 2026-02-02
Pharis Mohideen is a Chief Medical Officer who has filed 15 SEC Form 4 insider transactions across 2 companies since 2018. The most recent filing shows the insider sold $2.6K of DBVT on Feb 2, 2026. Across all open-market trades the lifetime net is −$43.7K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $2.5M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$2.53M
2
15
-$43.7K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| DBVT | Chief Medical Officer | 144,995 | $17.41 | $2.53M | -$43.7K | 13 | 2026-02-02 |
| Tempest Therapeutics, Inc. (MLND) Delisted | Chief Medical Officer | 7,440 | $15.90 | $118.3K | $0 | 2 | 2019-01-17 |
Recent Filings
15 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-02-02 | DBVT | Sell (S) | −534 | -$2.6K | EDGAR |
| 2025-11-25 | DBVT | Mixed | +35,880 | -$23.2K | EDGAR |
| 2025-07-31 | DBVT | Sell (S) | −464 | -$1.0K | EDGAR |
| 2025-05-27 | DBVT | Sell (S) | −397 | -$730 | EDGAR |
| 2025-01-31 | DBVT | Sell (S) | −600 | -$510 | EDGAR |
| 2024-11-27 | DBVT | Sell (S) | −907 | -$503 | EDGAR |
| 2024-11-25 | DBVT | Mixed | +32,650 | -$1.3K | EDGAR |
| 2024-07-31 | DBVT | Sell (S) | −1,785 | -$1.7K | EDGAR |
| 2024-05-29 | DBVT | Sell (S) | −1,042 | -$1.4K | EDGAR |
| 2023-12-19 | DBVT | Sell (S) | −2,245 | -$3.9K | EDGAR |